Headache News and Research

Latest Headache News and Research

Paxlovid does not reduce long COVID risk in vaccinated individuals, study finds

A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.

4 Jan 2024

Brain injury markers found in the blood months after COVID-19 infection

A new study published today (22 December 2023) in Nature Communications details that markers of brain injury are present in the blood many months after COVID-19 infection, despite inflammation blood tests being normal.

22 Dec 2023

Bold changes are in store for Medi-Cal in 2024, but will patients benefit?

California's safety-net health program, Medi-Cal, is on the cusp of major changes that could rectify long-standing problems and improve health care for the state's low-income population.

22 Dec 2023

Childhood trauma linked to chronic pain in adulthood

Physical, sexual, or emotional abuse, or neglect, either alone or combined with other types of childhood trauma, increases the risk of chronic pain and related disability in adulthood, according to new research.

19 Dec 2023

When a quick telehealth visit yields multiple surprises beyond a big bill

In September 2022, Elyse Greenblatt of Queens returned home from a trip to Rwanda with a rather unwelcome-back gift: persistent congestion.

19 Dec 2023

Experts call for valuing patient "lived experiences" in diagnostic decisions

Experts today call for more value to be given to patients' 'lived experiences' as a study of over 1,000 patients and clinicians found multiple examples of patient reports being under-valued.

18 Dec 2023

Psilocybin may benefit individuals with cancer and major depression

Results from a phase II clinical trial indicate that psilocybin, a hallucinogenic chemical found in certain mushrooms of the genus Psiloybe, may benefit individuals with cancer and major depression.

18 Dec 2023

Intranasal COVID-19 vaccine shows promise in reducing severe symptoms

Study evaluates the single-dose intranasal spray vaccine dNS1-RBD, finding it effective against symptomatic COVID-19, particularly in reducing severe symptoms and respiratory issues.

15 Dec 2023

Study exposes racial disparities in Lyme disease diagnosis and treatment times

Study reveals racial disparities in Lyme disease diagnosis and treatment, with Black patients experiencing longer delays and higher risks of disseminated disease compared to White patients.

14 Dec 2023

Varied early symptoms of bacterial meningitis in adults and children highlight diagnostic challenges

This study in Scientific Reports reveals that symptoms of community-acquired bacterial meningitis (CABM) vary between children and adults, emphasizing the need for tailored approaches in early diagnosis and treatment to improve outcomes.

10 Dec 2023

Paracetamol and ibuprofen equally effective for tension-type headaches, study reveals

A systematic review and meta-analysis in Scientific Reports finds no significant difference between paracetamol and ibuprofen in treating episodic tension-type headaches, suggesting both as viable options for pain relief.

7 Dec 2023

Imaging approach provides objective evidence for the involvement of neck muscles in primary headaches

Researchers have identified objective evidence of how the neck muscles are involved in primary headaches, according to a study being presented today at the annual meeting of the Radiological Society of North America.

29 Nov 2023

Researchers develop a new early alert model for pandemic predictions in Germany

An early alert indicator and trend forecasting model for pandemic situations in Germany.

29 Nov 2023

Half-dose Pfizer COVID booster nearly as effective as full dose with fewer side effects

Study compares the half-dose and full-dose Pfizer-BioNTech BNT162b2 COVID-19 booster in adults previously vaccinated with ChAdOx1, BBIBP-CorV, or Gam-COVID-Vac. It finds that the half-dose booster has fewer side effects and maintains similar immunogenicity, offering a viable option for booster vaccination strategies.

27 Nov 2023

Examining pedestrian injuries in motor vehicle accidents: epidemiology and outcome analysis

Epidemiology of head injuries in pedestrian-motor vehicle accidents.

22 Nov 2023

New study unravels the mystery of red wine headaches

A red wine may pair nicely with the upcoming Thanksgiving meal. But for some people, drinking red wine even in small amounts causes a headache.

20 Nov 2023

MHRA extends the license of two cystic fibrosis drugs for children aged two to five years old

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (15 November 2023) extended the licence of the cystic fibrosis medicines Kaftrio (ivacaftor, tezacaftor and elexacaftor) and Kalydeco (ivacaftor) for children aged two to five years old.

20 Nov 2023

Norwegian study looks at which medicines best prevent migraine

Migraine is more than just a headache. Often the pain is accompanied by nausea, vomiting, light sensitivity, and sound sensitivity.

17 Nov 2023

Study reveals acupuncture and massage as effective pain management in advanced cancer

In a clinical trial, acupuncture and massage therapy significantly reduced pain, fatigue, and insomnia, enhancing quality of life in advanced cancer patients over 26 weeks.

16 Nov 2023

Single injection of new medication effectively eliminates Lp(a) for nearly one year

In the first human trial of a new therapeutic, a single injection of lepodisiran reduced levels of lipoprotein(a), or Lp(a), to undetectable levels for nearly one year, according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2023.

13 Nov 2023

Headache News and Research

Latest Headache News and Research

Paxlovid does not reduce long COVID risk in vaccinated individuals, study finds

Brain injury markers found in the blood months after COVID-19 infection

Bold changes are in store for Medi-Cal in 2024, but will patients benefit?

Childhood trauma linked to chronic pain in adulthood

When a quick telehealth visit yields multiple surprises beyond a big bill

Experts call for valuing patient "lived experiences" in diagnostic decisions

Psilocybin may benefit individuals with cancer and major depression

Intranasal COVID-19 vaccine shows promise in reducing severe symptoms

Study exposes racial disparities in Lyme disease diagnosis and treatment times

Varied early symptoms of bacterial meningitis in adults and children highlight diagnostic challenges

Paracetamol and ibuprofen equally effective for tension-type headaches, study reveals

Imaging approach provides objective evidence for the involvement of neck muscles in primary headaches

Researchers develop a new early alert model for pandemic predictions in Germany

Half-dose Pfizer COVID booster nearly as effective as full dose with fewer side effects

Examining pedestrian injuries in motor vehicle accidents: epidemiology and outcome analysis

New study unravels the mystery of red wine headaches

MHRA extends the license of two cystic fibrosis drugs for children aged two to five years old

Norwegian study looks at which medicines best prevent migraine

Study reveals acupuncture and massage as effective pain management in advanced cancer

Single injection of new medication effectively eliminates Lp(a) for nearly one year

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Sensing a Healthier Future

Headache News and Research

Latest Headache News and Research

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Sensing a Healthier Future

Newsletters you may be interested in